Temat: "Antibiotics, Antitubercular" - OpacWWW

Skocz do pozycji: 41.

Tytuł:: Model-Informed Pediatric Dose Selection for Dapagliflozin by Incorporating Developmental Changes.
Autorzy:: Jo H; Modelling and Simulation, Early Oncology, Oncology R&D, AstraZeneca, Cambridge, UK.
Pilla Reddy V; Modelling and Simulation, Early Oncology, Oncology R&D, AstraZeneca, Cambridge, UK.; Clinical Pharmacology and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.
Parkinson J; Clinical Pharmacology and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Boulton DW; Clinical Pharmacology and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
Tang W; Clinical Pharmacology and Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.; Pokaż więcej
Źródło:: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2021 Feb; Vol. 10 (2), pp. 108-118. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji:: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Benzhydryl Compounds/*pharmacokinetics
Glucosides/*pharmacokinetics
Glucuronosyltransferase/*metabolism
Mefenamic Acid/*pharmacokinetics
Rifampin/*pharmacokinetics
Sodium-Glucose Transporter 2 Inhibitors/*pharmacokinetics
UDP-Glucuronosyltransferase 1A9/*metabolism
Administration, Oral ; Adolescent ; Antibiotics, Antitubercular/administration & dosage ; Antibiotics, Antitubercular/adverse effects ; Antibiotics, Antitubercular/pharmacokinetics ; Area Under Curve ; Child ; Child, Preschool ; Computer Simulation ; Cyclooxygenase Inhibitors/administration & dosage ; Cyclooxygenase Inhibitors/adverse effects ; Cyclooxygenase Inhibitors/pharmacokinetics ; Dose-Response Relationship, Drug ; Drug Interactions ; Female ; Healthy Volunteers/statistics & numerical data ; Hepatic Insufficiency/drug therapy ; Humans ; Infant ; Infant, Newborn ; Male ; Mefenamic Acid/administration & dosage ; Mefenamic Acid/adverse effects ; Models, Biological ; Predictive Value of Tests ; Renal Insufficiency/drug therapy ; Rifampin/administration & dosage ; Rifampin/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 42.

Tytuł:: Has universal screening with Xpert® MTB/RIF increased the proportion of multidrug-resistant tuberculosis cases diagnosed in a routine operational setting?
Autorzy:: Naidoo P; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Dunbar R; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.
Caldwell J; City Health Directorate, Cape Town, South Africa.
Lombard C; Biostatistics Unit, South African Medical Research Council, Cape Town, South Africa.
Beyers N; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2017 Feb 15; Vol. 12 (2), pp. e0172143. Date of Electronic Publication: 2017 Feb 15 (Print Publication: 2017).
Typ publikacji:: Journal Article
MeSH Terms:: Antibiotics, Antitubercular/*pharmacology
Mycobacterium tuberculosis/*drug effects
Tuberculosis, Multidrug-Resistant/*diagnosis
Adult ; Algorithms ; Antibiotics, Antitubercular/therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Mycobacterium tuberculosis/growth & development ; Mycobacterium tuberculosis/isolation & purification ; Reagent Kits, Diagnostic ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/microbiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 43.

Tytuł:: Rifampicin exposure reveals within-host Mycobacterium tuberculosis diversity in patients with delayed culture conversion.
Autorzy:: Genestet C; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Hospices Civils de Lyon, Institut des Agents Infectieux, Laboratoire de bactériologie, Lyon, France.
Hodille E; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Hospices Civils de Lyon, Institut des Agents Infectieux, Laboratoire de bactériologie, Lyon, France.
Barbry A; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Hospices Civils de Lyon, Institut des Agents Infectieux, Laboratoire de bactériologie, Lyon, France.
Berland JL; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Fondation Mérieux, Emerging Pathogens Laboratory, Lyon, France.
Hoffmann J; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Fondation Mérieux, Emerging Pathogens Laboratory, Lyon, France.
Westeel E; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Fondation Mérieux, Emerging Pathogens Laboratory, Lyon, France.
Bastian F; Plateforme DTAMB, CNRS, Université Lyon 1, Villeurbanne, France.
Guichardant M; CarMeN laboratory, INSA Lyon, INSERM U1060, INRA U1397, Université Lyon 1, Villeurbanne, France.
Venner S; Laboratoire de Biométrie et Biologie Évolutive, CNRS UMR 5558, Université Lyon 1, Villeurbanne, France.
Lina G; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Hospices Civils de Lyon, Institut des Agents Infectieux, Laboratoire de bactériologie, Lyon, France.; Université Lyon 1, Facultés de Médecine et de Pharmacie de Lyon, Lyon, France.
Ginevra C; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Hospices Civils de Lyon, Institut des Agents Infectieux, Laboratoire de bactériologie, Lyon, France.
Ader F; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Hospices Civils de Lyon, Service des Maladies infectieuses et tropicales, Lyon, France.
Goutelle S; Laboratoire de Biométrie et Biologie Évolutive, CNRS UMR 5558, Université Lyon 1, Villeurbanne, France.; Université Lyon 1, Facultés de Médecine et de Pharmacie de Lyon, Lyon, France.; Hospices Civils de Lyon, Groupement Hospitalier Nord, Service pharmaceutique, Lyon, France.
Dumitrescu O; CIRI-Centre International de Recherche en Infectiologie, Ecole Normale Supérieure de Lyon, Université Claude Bernard Lyon-1, Inserm U1111, CNRS UMR5308, Lyon, France.; Hospices Civils de Lyon, Institut des Agents Infectieux, Laboratoire de bactériologie, Lyon, France.; Université Lyon 1, Facultés de Médecine et de Pharmacie de Lyon, Lyon, France.; Pokaż więcej
Źródło:: PLoS pathogens [PLoS Pathog] 2021 Jun 24; Vol. 17 (6), pp. e1009643. Date of Electronic Publication: 2021 Jun 24 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibiotics, Antitubercular/*therapeutic use
Drug Resistance, Bacterial/*genetics
Mycobacterium tuberculosis/*genetics
Rifampin/*therapeutic use
Tuberculosis/*microbiology
Humans ; Polymorphism, Single Nucleotide ; Tuberculosis/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 44.

Tytuł:: High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey.
Autorzy:: Lansang MAD; Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, Philippines.; Division of Infectious Diseases, Department of Medicine, College of Medicine, University of the Philippines-Philippine General Hospital, Manila, Philippines.
Alejandria MM; Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, Philippines.; Division of Infectious Diseases, Department of Medicine, College of Medicine, University of the Philippines-Philippine General Hospital, Manila, Philippines.
Law I; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland.
Juban NR; Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, Philippines.
Amarillo MLE; Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, Philippines.
Sison OT; Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines, Manila, Philippines.
Cruz JRB; Foundation for the Advancement of Clinical Epidemiology, Manila, Philippines.; Social Innovation in Health Initiative, University of the Philippines, Manila, Philippines.
Ang CF; Foundation for the Control of Infectious Diseases, Taft Avenue, Manila, Philippines.
Buensalido JAL; Division of Infectious Diseases, Department of Medicine, College of Medicine, University of the Philippines-Philippine General Hospital, Manila, Philippines.
Cañal JPA; Department of Radiology, University of the Philippines College of Medicine, University of the Philippines, Manila, Philippines.; Philippine College of Radiology, Quezon City, Philippines.
Castillo-Carandang NT; Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, Philippines.; Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines, Manila, Philippines.
Cordero CP; Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, Philippines.
Gaviola DMG; Department of Health, National TB Control Program, Manila, Philippines.
Ladia MAJ; Institute of Clinical Epidemiology, National Institutes of Health, University of the Philippines, Manila, Philippines.
Mantaring JBV 3rd; Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, Philippines.; Foundation for the Advancement of Clinical Epidemiology, Manila, Philippines.
Mendoza MT; Division of Infectious Diseases, Department of Medicine, College of Medicine, University of the Philippines-Philippine General Hospital, Manila, Philippines.; Foundation for the Control of Infectious Diseases, Taft Avenue, Manila, Philippines.
Salamat MSS; Division of Infectious Diseases, Department of Medicine, College of Medicine, University of the Philippines-Philippine General Hospital, Manila, Philippines.
Lam HY; Department of Clinical Epidemiology, College of Medicine, University of the Philippines, Manila, Philippines.; Institute of Health Policy and Development Studies, University of the Philippines, Manila, Philippines.
Tadolini M; Infectious Diseases Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italy.; Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Garfin AMCG; Department of Health, National TB Control Program, Manila, Philippines.; Pokaż więcej
Corporate Authors:: Philippine NTPS 2016 Group
Źródło:: PloS one [PLoS One] 2021 Jun 04; Vol. 16 (6), pp. e0252240. Date of Electronic Publication: 2021 Jun 04 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Tuberculosis, Pulmonary/*epidemiology
Adolescent ; Adult ; Aged ; Antibiotics, Antitubercular/therapeutic use ; Cough/microbiology ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Mycobacterium tuberculosis/drug effects ; Philippines/epidemiology ; Prevalence ; Sputum/microbiology ; Surveys and Questionnaires ; Thorax/microbiology ; Tuberculosis, Pulmonary/drug therapy ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 45.

Tytuł:: Performance of the G4 Xpert MTB/RIF assay for the detection of Mycobacterium tuberculosis and rifampin resistance: a retrospective case-control study of analytical and clinical samples from high- and low-tuberculosis prevalence settings.
Autorzy:: Dharan NJ; Department of Medicine, New Jersey Medical School, Rutgers, The State University of New Jersey, 185 South Orange Avenue, MSB I-689, Newark, NJ, 07103, USA. .
Blakemore R; Department of Medicine, New Jersey Medical School, Rutgers, The State University of New Jersey, 185 South Orange Avenue, MSB I-689, Newark, NJ, 07103, USA.; Current address: Sackler School of Graduate Biomedical Science - Tufts University, Boston, MA, USA.
Sloutsky A; University of Massachusetts Medical School, Worcester, MA, USA.
Kaur D; University of Massachusetts Medical School, Worcester, MA, USA.
Alexander RC; Orange County Health Care Agency, Santa Ana, CA, USA.
Ghajar M; Orange County Health Care Agency, Santa Ana, CA, USA.
Musser KA; Wadsworth Center, New York State Department of Health, Albany, NY, USA.
Escuyer VE; Wadsworth Center, New York State Department of Health, Albany, NY, USA.
Rowlinson MC; Florida Department of Health, Jacksonville, FL, USA.
Crowe S; Florida Department of Health, Jacksonville, FL, USA.
Laniado-Laborin R; Clínica y Laboratorio de Tuberculosis, Hospital General Tijuana, Tijuana, Mexico.
Valli E; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
Nabeta P; Foundation for Innovative New Diagnostics, Geneva, Switzerland.
Johnson P; Cepheid, Sunnyvale, CA, USA.
Alland D; Department of Medicine, New Jersey Medical School, Rutgers, The State University of New Jersey, 185 South Orange Avenue, MSB I-689, Newark, NJ, 07103, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2016 Dec 20; Vol. 16 (1), pp. 764. Date of Electronic Publication: 2016 Dec 20.
Typ publikacji:: Journal Article
MeSH Terms:: Antibiotics, Antitubercular*
Rifampin*
Drug Resistance, Bacterial/*genetics
Mycobacterium tuberculosis/*isolation & purification
Tuberculosis/*diagnosis
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Biological Assay ; Case-Control Studies ; DNA, Bacterial/analysis ; Developing Countries ; False Positive Reactions ; Female ; Humans ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Mutation ; Mycobacterium tuberculosis/genetics ; Polymerase Chain Reaction/methods ; Prevalence ; Retrospective Studies ; Sensitivity and Specificity ; Tuberculosis/epidemiology ; Tuberculosis/microbiology ; United States/epidemiology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 46.

Tytuł:: Application of the Multistate Tuberculosis Pharmacometric Model in Patients With Rifampicin-Treated Pulmonary Tuberculosis.
Autorzy:: Svensson RJ; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Simonsson U; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.; Pokaż więcej
Źródło:: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2016 May; Vol. 5 (5), pp. 264-73. Date of Electronic Publication: 2016 May 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Computer Simulation*
Models, Biological*
Antibiotics, Antitubercular/*therapeutic use
Rifampin/*therapeutic use
Tuberculosis, Pulmonary/*drug therapy
Antibiotics, Antitubercular/pharmacokinetics ; Clinical Trials, Phase II as Topic/statistics & numerical data ; Humans ; Models, Theoretical ; Rifampin/pharmacokinetics ; Stem Cells/drug effects ; Stem Cells/metabolism ; Treatment Outcome ; Tuberculosis, Pulmonary/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 47.

Tytuł:: The impact of chest radiography and Xpert MTB/RIF testing among household contacts in Chennai, India.
Autorzy:: Ananthakrishnan R; REACH - Resource Group for Education and Advocacy for Community Health, Chennai, Tamil Nadu, India.
Thiagesan R; REACH - Resource Group for Education and Advocacy for Community Health, Chennai, Tamil Nadu, India.
Auguesteen S; REACH - Resource Group for Education and Advocacy for Community Health, Chennai, Tamil Nadu, India.
Karunakaran N; REACH - Resource Group for Education and Advocacy for Community Health, Chennai, Tamil Nadu, India.
Jayabal L; GCC RNTCP - Greater Chennai Corporation Revised National Tuberculosis Control Programme Chennai, Tamil Nadu, India.
M J; GCC RNTCP - Greater Chennai Corporation Revised National Tuberculosis Control Programme Chennai, Tamil Nadu, India.
Stevens R; Independent Consultant, Manchester, United Kingdom.
Codlin A; Stop TB Partnership, TB REACH, Geneva, Switzerland.
Creswell J; Stop TB Partnership, TB REACH, Geneva, Switzerland.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Nov 04; Vol. 15 (11), pp. e0241203. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Contact Tracing/*methods
Mass Screening/*methods
Mycobacterium tuberculosis/*isolation & purification
Sputum/*microbiology
Tuberculosis, Pulmonary/*diagnosis
Adolescent ; Adult ; Antibiotics, Antitubercular/pharmacology ; Antibiotics, Antitubercular/therapeutic use ; Contact Tracing/statistics & numerical data ; Drug Resistance, Bacterial ; Female ; Humans ; India/epidemiology ; Male ; Mass Screening/statistics & numerical data ; Microscopy ; Middle Aged ; Molecular Diagnostic Techniques/statistics & numerical data ; Radiography/statistics & numerical data ; Reagent Kits, Diagnostic/statistics & numerical data ; Retrospective Studies ; Rifampin ; Tuberculosis, Pulmonary/drug therapy ; Tuberculosis, Pulmonary/epidemiology ; Tuberculosis, Pulmonary/microbiology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 48.

Tytuł:: Performance of Xpert MTB/RIF Ultra for diagnosis of pulmonary and extra-pulmonary tuberculosis, one year of use in a multi-centric hospital laboratory in Brussels, Belgium.
Autorzy:: Mekkaoui L; Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.
Hallin M; Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.
Mouchet F; Pediatric Department, CHU Saint Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Payen MC; Department of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Maillart E; Department of Infectious Diseases, Hôpital Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
Clevenbergh P; Department of Infectious Diseases, Hôpital Universitaire Brugmann, Université Libre de Bruxelles, Brussels, Belgium.
Georgala A; Department of Infectious Diseases, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
Van den Wijngaert S; Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles-Universitair Laboratorium Brussel (LHUB-ULB), Brussels, Belgium.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Apr 08; Vol. 16 (4), pp. e0249734. Date of Electronic Publication: 2021 Apr 08 (Print Publication: 2021).
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Diagnostic Tests, Routine/*methods
Mycobacterium tuberculosis/*pathogenicity
Tuberculosis, Pulmonary/*diagnosis
Adult ; Antibiotics, Antitubercular/pharmacology ; Belgium ; Child, Preschool ; Drug Resistance, Bacterial/drug effects ; False Negative Reactions ; False Positive Reactions ; Female ; Humans ; Laboratories, Hospital ; Male ; Microbial Sensitivity Tests/methods ; Middle Aged ; Mycobacterium tuberculosis/drug effects ; Sensitivity and Specificity ; Sputum/microbiology ; Tuberculosis, Multidrug-Resistant/diagnosis ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Pulmonary/drug therapy ; Tuberculosis, Pulmonary/microbiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 49.

Tytuł:: Development and performance of CUHAS-ROBUST application for pulmonary rifampicin-resistance tuberculosis screening in Indonesia.
Autorzy:: Herman B; College of Public Health Science, Chulalongkorn University, Bangkok, Thailand.
Sirichokchatchawan W; College of Public Health Science, Chulalongkorn University, Bangkok, Thailand.
Pongpanich S; College of Public Health Science, Chulalongkorn University, Bangkok, Thailand.
Nantasenamat C; Faculty of Medical Technology, Mahidol University, Salaya, Nakhon Pathom, Thailand.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Mar 25; Vol. 16 (3), pp. e0249243. Date of Electronic Publication: 2021 Mar 25 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Drug Resistance, Bacterial*
Neural Networks, Computer*
Antibiotics, Antitubercular/*therapeutic use
Rifampin/*therapeutic use
Tuberculosis/*drug therapy
Adult ; Area Under Curve ; Cross-Sectional Studies ; Female ; Humans ; Indonesia ; Logistic Models ; Male ; Middle Aged ; Mycobacterium tuberculosis ; ROC Curve ; Sensitivity and Specificity ; Tuberculosis/diagnosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 50.

Tytuł:: Comparing the impact of genotypic based diagnostic algorithm on time to treatment initiation and treatment outcomes among drug-resistant tuberculosis patients in Amhara region, Ethiopia.
Autorzy:: Kassa GM; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Merid MW; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Muluneh AG; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Wolde HF; Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Feb 18; Vol. 16 (2), pp. e0246938. Date of Electronic Publication: 2021 Feb 18 (Print Publication: 2021).
Typ publikacji:: Comparative Study; Journal Article; Observational Study
MeSH Terms:: Antibiotics, Antitubercular/*therapeutic use
Mycobacterium tuberculosis/*drug effects
Tuberculosis, Multidrug-Resistant/*diagnosis
Tuberculosis, Multidrug-Resistant/*drug therapy
Adult ; Ethiopia/epidemiology ; Female ; Humans ; Male ; Mycobacterium tuberculosis/genetics ; Retrospective Studies ; Time-to-Treatment ; Treatment Outcome ; Tuberculosis, Multidrug-Resistant/epidemiology ; Tuberculosis, Multidrug-Resistant/microbiology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 51.

Tytuł:: Bullous pemphigoid in adolescence, a rare demographic.
Autorzy:: Brown H; Kotara Family Practice, Kotara, New South Wales, Australia.
Lamrock E; Department of Dermatology, John Hunter Hospital, New Lambton, New South Wales, Australia.
Jenkins D; Department of Dermatology, John Hunter Hospital, New Lambton, New South Wales, Australia.; Pokaż więcej
Źródło:: The Australasian journal of dermatology [Australas J Dermatol] 2021 Feb; Vol. 62 (1), pp. e95-e97. Date of Electronic Publication: 2020 Sep 16.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Pemphigoid, Bullous/*pathology
Adolescent ; Anti-Inflammatory Agents/therapeutic use ; Antibiotics, Antitubercular/therapeutic use ; Betamethasone/analogs & derivatives ; Betamethasone/therapeutic use ; Female ; Glucocorticoids/therapeutic use ; Humans ; Methylprednisolone/analogs & derivatives ; Methylprednisolone/therapeutic use ; Mycophenolic Acid/therapeutic use ; Pemphigoid, Bullous/drug therapy ; Prednisone/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 52.

Tytuł:: Antimycobacterial action of a new glycolipid-peptide complex obtained from extracellular metabolites of Raoultella ornithinolytica.
Autorzy:: Fiołka MJ; Department of Immunobiology, Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Lublin, Poland.
Grzywnowicz K; Department of Biochemistry, Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Lublin, Poland.
Mendyk E; Analytical Laboratory, Faculty of Chemistry, Maria Curie-Skłodowska University, Lublin, Poland.
Zagaja M; Isobolographic Analysis Laboratory, Institute of Rural Health, Lublin, Poland.
Szewczyk R; Department of Industrial Microbiology and Biotechnology, Institute of Microbiology, Biotechnology and Immunology, University of Łódź, Łódź
Rawski M; Analytical Laboratory, Faculty of Chemistry, Maria Curie-Skłodowska University, Lublin, Poland.
Keller R; Analytical Laboratory, Faculty of Chemistry, Maria Curie-Skłodowska University, Lublin, Poland.
Rzymowska J; Department of Biology and Genetics, Medical University of Lublin, Lublin, Poland.
Wydrych J; Department of Comparative Anatomy and Anthropology, Institute of Biology and Biochemistry, Maria Curie-Skłodowska University, Lublin, Poland.; Pokaż więcej
Źródło:: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2015 Dec; Vol. 123 (12), pp. 1069-80.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibiotics, Antitubercular/*pharmacology
Enterobacteriaceae/*chemistry
Glycolipids/*pharmacology
Mycobacterium smegmatis/*drug effects
Oligochaeta/*microbiology
Peptides/*pharmacology
Animals ; Antibiotics, Antitubercular/chemistry ; Antibiotics, Antitubercular/isolation & purification ; Fibroblasts/drug effects ; Glycolipids/chemistry ; Glycolipids/isolation & purification ; Humans ; Microbial Sensitivity Tests ; Microscopy, Atomic Force ; Molecular Sequence Data ; Nisin/chemistry ; Nisin/pharmacology ; Peptides/chemistry ; Peptides/isolation & purification ; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 53.

Tytuł:: Integrating Xpert MTB/RIF for TB diagnosis in the private sector: evidence from large-scale pilots in Patna and Mumbai, India.
Autorzy:: Deo S; Indian School of Business, AC 3, L1, #3113, ISB Campus, Gachibowli, Hyderabad, 500032, India. sarang_.
Jindal P; Indian School of Business, AC 3, L1, #3113, ISB Campus, Gachibowli, Hyderabad, 500032, India.; UCLA Anderson School of Management, Los Angeles, United States.
Papineni S; Harvard Medical School, Boston, United States.; World Health Partners, New Delhi, India.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2021 Jan 28; Vol. 21 (1), pp. 123. Date of Electronic Publication: 2021 Jan 28.
Typ publikacji:: Journal Article
MeSH Terms:: Molecular Diagnostic Techniques/*statistics & numerical data
Mycobacterium tuberculosis/*isolation & purification
Private Sector/*statistics & numerical data
Tuberculosis/*diagnosis
Antibiotics, Antitubercular/therapeutic use ; Drug Resistance, Bacterial/genetics ; Humans ; India/epidemiology ; Mycobacterium tuberculosis/genetics ; Pilot Projects ; Practice Patterns, Physicians'/statistics & numerical data ; Rifampin/therapeutic use ; Tuberculosis/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 54.

Tytuł:: The Emerging Challenge of Diagnosing Drug-resistant Tubercular Uveitis: Experience of 110 Eyes from North India.
Autorzy:: Sharma K; Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Gupta A; Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sharma M; Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sharma A; Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Bansal R; Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Sharma SP; Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Singh RD; Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Gupta V; Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.; Pokaż więcej
Źródło:: Ocular immunology and inflammation [Ocul Immunol Inflamm] 2021 Jan 02; Vol. 29 (1), pp. 107-114. Date of Electronic Publication: 2019 Oct 03.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Eye Infections, Bacterial/*diagnosis
Rifampin/*pharmacology
Tuberculosis, Multidrug-Resistant/*diagnosis
Uveitis/*diagnosis
Adolescent ; Adult ; Antibiotics, Antitubercular/pharmacology ; Bacterial Proteins/analysis ; Bacterial Proteins/genetics ; DNA, Bacterial/analysis ; DNA-Directed RNA Polymerases/analysis ; DNA-Directed RNA Polymerases/genetics ; Eye Infections, Bacterial/drug therapy ; Eye Infections, Bacterial/epidemiology ; Female ; Humans ; India/epidemiology ; Male ; Middle Aged ; Mycobacterium tuberculosis/genetics ; Prevalence ; Retrospective Studies ; Tuberculosis, Multidrug-Resistant/drug therapy ; Tuberculosis, Multidrug-Resistant/epidemiology ; Uveitis/drug therapy ; Uveitis/epidemiology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 55.

Tytuł:: Cell membrane components of Brucella melitensis play important roles in the resistance of low-level rifampicin.
Autorzy:: Yang X; State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Key Laboratory of Animal Epidemiology and Zoonosis of the Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing, China.
Wu T; College of Animal Science and Technology, Hebei Normal University of Science & Technology, Qinhuangdao, China.
Liu W; Beijing Key Laboratory for Prevention and Control of Infectious Disease in Livestock and Poultry, Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agricultural and Forestry Sciences, Beijing, China.
Tian G; State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Zhao H; State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Piao D; State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jiang H; State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Wu Q; Key Laboratory of Animal Epidemiology and Zoonosis of the Ministry of Agriculture, College of Veterinary Medicine, China Agricultural University, Beijing, China.; Pokaż więcej
Źródło:: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Dec 29; Vol. 14 (12), pp. e0008888. Date of Electronic Publication: 2020 Dec 29 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibiotics, Antitubercular/*pharmacology
Brucella melitensis/*drug effects
Rifampin/*pharmacology
Bacterial Proteins/genetics ; Bacterial Proteins/metabolism ; Cell Membrane ; DNA-Directed RNA Polymerases/genetics ; DNA-Directed RNA Polymerases/metabolism ; Drug Resistance, Bacterial ; Gene Expression Regulation, Bacterial ; Genome, Bacterial ; Microbial Sensitivity Tests ; Rifampin/administration & dosage

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 56.

Tytuł:: A retrospective cohort study of early mortality among patients with HIV/TB co-infection in Shanghai municipality.
Autorzy:: Qi TK; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Chen J; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Zhang RF; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Liu L; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Shen YZ; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Wang ZY; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Sun JJ; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Song W; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Tang Y; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Wang JR; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Ling YX; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Xu SB; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Yang JY; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.
Lu HZ; Department of Infectious Diseases and Immunology, Shanghai Public Health Clinical Center, Shanghai, China.; Pokaż więcej
Źródło:: HIV medicine [HIV Med] 2020 Dec; Vol. 21 (11), pp. 739-746.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibiotics, Antitubercular/*therapeutic use
Coinfection/*mortality
HIV Infections/*microbiology
Tuberculosis/*mortality
Adult ; Aged ; China/epidemiology ; Female ; HIV Infections/mortality ; Hospitalization ; Humans ; Male ; Middle Aged ; Prevalence ; Regression Analysis ; Retrospective Studies ; Rifabutin/therapeutic use ; Rifampin/therapeutic use ; Risk Factors ; Tuberculosis/drug therapy ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 57.

Tytuł:: Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: A cross sectional study.
Autorzy:: Wasihun AG; Department of Medical Microbiology and Immunology, School of Medicine, Mekelle University, Mekelle, Ethiopia.
Dejene TA; Department of Medical Microbiology and Immunology, School of Medicine, Mekelle University, Mekelle, Ethiopia.; Department of Medical Microbiology and Immunology, School of Medicine, Aksum University, Aksum, Ethiopia.
Hailu GG; Department of Medical Microbiology and Immunology, School of Medicine, Mekelle University, Mekelle, Ethiopia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Nov 04; Vol. 15 (11), pp. e0240361. Date of Electronic Publication: 2020 Nov 04 (Print Publication: 2020).
Typ publikacji:: Journal Article; Multicenter Study
MeSH Terms:: Drug Resistance, Multiple, Bacterial/*drug effects
Mycobacterium tuberculosis/*drug effects
Rifampin/*pharmacology
Tuberculosis, Multidrug-Resistant/*drug therapy
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibiotics, Antitubercular/pharmacology ; Biological Assay/methods ; Cross-Sectional Studies ; Ethiopia/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Mycobacterium tuberculosis/physiology ; Retrospective Studies ; Tuberculosis, Multidrug-Resistant/epidemiology ; Tuberculosis, Multidrug-Resistant/microbiology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 58.

Tytuł:: The Bairnsdale ulcer (Mycobacterium ulcerans) in an urban Victorian practice: A case series.
Autorzy:: Jerjen R; Sinclair Dermatology, East Melbourne, Victoria, Australia.
Moodley A; Sinclair Dermatology, East Melbourne, Victoria, Australia.; UKZN University of KwaZulu-Natal, Durban, South Africa.
Sinclair R; Sinclair Dermatology, East Melbourne, Victoria, Australia.; Pokaż więcej
Źródło:: The Australasian journal of dermatology [Australas J Dermatol] 2020 Nov; Vol. 61 (4), pp. 376-377. Date of Electronic Publication: 2020 Jun 23.
Typ publikacji:: Case Reports; Letter
MeSH Terms:: Buruli Ulcer/*diagnosis
Buruli Ulcer/*drug therapy
Adolescent ; Aged ; Antibiotics, Antitubercular/therapeutic use ; Clarithromycin/therapeutic use ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Mycobacterium ulcerans ; Rifampin/therapeutic use ; Victoria

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 59.

Tytuł:: Unraveling Comparative Anti-Amyloidogenic Behavior of Pyrazinamide and D-Cycloserine: A Mechanistic Biophysical Insight.
Autorzy:: Chaturvedi SK; Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
Zaidi N; Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
Alam P; Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
Khan JM; Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
Qadeer A; Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
Siddique IA; Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
Asmat S; Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.
Zaidi Y; Department of Zoology, Aligarh Muslim University, Aligarh, 202002, India.
Khan RH; Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, India.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Aug 27; Vol. 10 (8), pp. e0136528. Date of Electronic Publication: 2015 Aug 27 (Print Publication: 2015).
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Protein Aggregates*
Amyloid beta-Peptides/*chemistry
Antibiotics, Antitubercular/*chemistry
Cycloserine/*chemistry
Muramidase/*chemistry
Peptide Fragments/*chemistry
Pyrazinamide/*chemistry
Alzheimer Disease/drug therapy ; Alzheimer Disease/metabolism ; Amyloid beta-Peptides/metabolism ; Animals ; Antibiotics, Antitubercular/pharmacology ; Chickens ; Cycloserine/pharmacology ; Muramidase/metabolism ; PC12 Cells ; Peptide Fragments/metabolism ; Pyrazinamide/pharmacology ; Rats

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 60.

Tytuł:: Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.
Autorzy:: van Kampen SC; Access to Laboratory Services Team, KNCV Tuberculosis Foundation, The Hague, the Netherlands.
Susanto NH; Medical Faculty, Universitas Padjadjaran, Bandung, Indonesia; Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia.
Simon S; Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia; Medical Faculty, Universitas Atmadjaja, Jakarta, Indonesia.
Astiti SD; Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia.
Chandra R; Laboratory Team TB CARE I, KNCV Tuberculosis Foundation, Jakarta, Indonesia.
Burhan E; Department of Lung and Respiratory Health, Persahabatan Hospital, Jakarta, Indonesia.
Farid MN; Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia; Sub-Directorate Statistics and Design, Central Bureau of Statistics, Jakarta, Indonesia.
Chittenden K; Health Division, United States Agency for International Development, Jakarta, Indonesia.
Mustikawati DE; National Tuberculosis Control Program, Ministry of Health, Jakarta, Indonesia.
Alisjahbana B; Medical Faculty, Universitas Padjadjaran, Bandung, Indonesia; Tuberculosis Operational Research Group, Ministry of Health, Jakarta, Indonesia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2015 Jun 15; Vol. 10 (6), pp. e0123536. Date of Electronic Publication: 2015 Jun 15 (Print Publication: 2015).
Typ publikacji:: Journal Article
MeSH Terms:: Drug Resistance, Bacterial*
Microbial Sensitivity Tests*
Antibiotics, Antitubercular/*pharmacology
Mycobacterium tuberculosis/*drug effects
Mycobacterium tuberculosis/*genetics
Rifampin/*pharmacology
Tuberculosis, Multidrug-Resistant/*diagnosis
Tuberculosis, Multidrug-Resistant/*epidemiology
Adolescent ; Adult ; Aged ; Antibiotics, Antitubercular/therapeutic use ; Child ; Child, Preschool ; Female ; Humans ; Indonesia/epidemiology ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Population Surveillance ; Rifampin/therapeutic use ; Tuberculosis, Multidrug-Resistant/drug therapy ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Antibiotics, Antitubercular"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język